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Abstract ICE family proteases have been implicated as 
important effectors of the apoptotic pathway, perhaps acting 
hierarchically in a protease cascade. Using cleavage of 
endogenous protease substrates as probes, three distinct tiers of 
ICE-fike activity were observed after Fas ligation in Jurkat cells. 
The earliest cleavage detected (30 min) was of fodrin, and 
produced a 150 kDa fragment. The second phase of cleavage (50 
rain) involved PARP, U1-70kDa and DNA-PK~, all substrates 
of the CPP32-1ike proteases. Lamin B cleavage was observed 
during the third cleavage phase (90 min). Distinct inhibition 
proffies obtained using a panel of peptide-based inhibitors of 
ICE-like proteases clearly distinguished the three different 
cleavage phases. These studies provide evidence for a sequence 
of ICE-like proteolytic activity during apoptosis. The early 
fodrin cleavage, producing a 150 kDa fragment, identifies an 
ICE-like activity proximal to CPP32 in Fas-induced Jurkat cell 
apoptosis. 
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1. Introduction 
Protease activity has been placed early in the final common 
pathway of apoptosis, and the importance of the interleukin 
l[3-converting enzyme (ICE) family of proteases has been em- 
phasized [1,2]. In mammals, the extended ICE family includes 
at least seven members [3], which have been divided into sev- 
eral subfamilies with homology to the prototype proteases 
ICE, CPP32 and Ich-1 [4]. The effects of these proteases in 
apoptosis appear to be accomplished by the cleavage of key 
homeostatic ellular substrates including poly (ADP-ribose) 
polymerase (PARP) [5], the 70 kDa subunit of the U1 ribo- 
nucleoprotein (U1 70kDa) [6], the catalytic subunit of the 
DNA-dependent protein kinase (DNA-P I~)  [7], sterol regu- 
latory element binding protein [8], and the GDP dissociation 
inhibitor protein D4-GDI  [9], as well as cleavage of several 
structural proteins including fodrin [10], lamin B [11], nuclear 
mitotic apparatus protein (NuMA) [12], and Gas-2 [13]. Re- 
cent studies have demonstrated that the protease subfamilies 
have distinct substrate specificities [14], and different kinetics 
of activation after delivery of an apoptotic signal [15]. 
Although all homologs studied to date have an absolute re- 
quirement for Asp in the Px position, ICE prefers a hydro- 
phobic residue in P4 [14], while CPP32 has a stringent require- 
ment for another Asp at this position [16]. 
Because a large proportion of treated cells rapidly undergo 
*Corresponding author. Fax: (1) (410) 955-0964. 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. 
PII S00 1 4 -5793(96)00678-3  
apoptosis, Fas ligation of Jurkat cells has been a useful system 
for the biochemical analysis of apoptosis in intact cells [17]. In 
these studies, we demonstrate that substrates cleaved in apop- 
totic cells can be separated into at least three groups, based on 
time-course of cleavage and sensitivity to various inhibitors of 
ICE-like proteases. Study of these cleavage vents will allow 
elucidation of the sequential proteolytic steps along the apop- 
totic pathway. 
2. Materials and methods 
Leupeptin, antipain, pepstatin A, chymostatin, and Nonidet P-40 
(NP-40) were purchased from Calbiochem. Phenylmethylsulfonyl 
fluoride (PMSF) was obtained from Sigma. Monoclonal antibodies 
were purchased from the following sources: CH-I 1 anti-Fas antibody 
was from Panvera (Madison, WI); anti-fodrin (non-erythroid spec- 
trin) antibody was from Chemicon International (Temecula, CA), 
anti-lamin B antibody 101-B7 and anti-NuMA antibody 107-7 were 
from Matritech (Cambridge, MA). Monoclonal antibody 18-2 that 
recognizes the intact form and the 250 kDa fragment of DNA-PI~s 
was a kind gift of Dr. Tim Carter (St. John's University, Jamaica, 
NY). The protease inhibitor zVAD-fmk was from Enzyme Systems 
Products (Dublin, CA); Ac-YVAD-CHO and Ac-DEVD-CHO were 
from Merck Research Laboratories (Rahway, NJ). The Supersignal 
CL-HRP substrate system used to visualize blotted proteins was pur- 
chased from Pierce. Nitrocellulose and PVDF membranes were pur- 
chased from Millipore. All other reagents and compounds were ana- 
lytical grade. 
2.1. Cell culture and induction of apoptosis 
Jurkat cells were maintained in RPMI containing 10% heat-inacti- 
vated fetal calf serum, using standard tissue culture procedures. When 
performing experiments, cells were washed and resuspended at8 × 106 
cells/ml in culture medium, in the absence or presence of 200 ~tM CH- 
11 anti-Fas antibody. After incubating for the indicated times at 37°C, 
the ceils were immediately chilled to 4°C and washed with ice-cold 
phosphate-buffered saline. 
2.2. Gel electrophoresis and immunoblotting for detection of 
DNA-PKcs, U1-7OkDa, PARP, fodrin, NuMA, and lamin B 
Ceils were lysed at 4°C in buffer containing 1% NP-40, 20 mM Tris, 
pH 7.4, 1 mM NaC1, 1 mM EDTA, and the following protease in- 
hibitors: pepstatin A, leupeptin, antipain, chymostatin, and PMSF. 
37.5 ktg of the reduced gel samples were electrophoresed on 10% SDS- 
polyacrylamide gels containing 0.087% bisacrylamide, and proteins 
were transferred to nitrocellulose [6]. Proteins were immunoblotted 
with patient sera recognizing U1-70kDa, PARP, and NuMA (serum 
RW [7]) or monoclonal antibodies raised against DNA-PK~s and fo- 
drin. Identical results were obtained using serum AG [7] to detect 
intact DNA-PI¢~ and the 160 kDa fragment (data not shown) and 
with monoclonal antibody 107-7 to detect NuMA (data not shown). 
Blotted proteins were visualized using an enhanced chemiluminescent 
substrate according to the manufacturer's instructions. Alternatively, 
the cells were lysed by freeze-thawing four times followed by centrif- 
ugation for 10 min at 230000×g in a TL100 ultracentrifuge (Beck- 
man). Pellets were solubilized in an equal volume of lysis buffer [18], 
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and aliquots of the pellet were separated by SDS PAGE on 16% 
(lamin B) or 4-20% (PARP) Novex gels. Gels were transferred to 
PVDF membranes, and immunoblots were performed as described 
above. The protein fragments observed in apoptotic ells were never 
seen in immunoblots ofcontrol cells. 
2.3. Protease &hibitor experiments 
Jurkat cells were pre-incubated for15 min at 37°C in the absence or 
presence ofthe following protease inhibitors: 10 gM zVAD-fmk, 100 
gM Ac-YVAD-CHO, or 100 gM Ac-DEVD-CHO. Cells were then 
induced to undergo apoptosis by incubating with 200 ng/ml CH-11 
anti-Fas antibody for 90 min prior to chilling, lysing, and immuno- 
blotting as described above. Incubation with the protease inhibitors in 
the absence of Fas ligation did not produce the apoptotic protein 
fragments (data not shown). 
2.4. DATA extract&n and gels 
DNA from whole cell populations, harvested atthe indicated times 
after Fas ligation, was extracted, processed, and electrophoresed on 
1.5% agarose gels as described [19]. 
3. Results and discussion 
3.1. Cleavage of endogenous substrates occurs in three phases 
in Fas-ligated Jurkat cells 
To characterize the order of cleavage of endogenous macro- 
molecular substrates in intact cells, apoptosis was induced in 
Jurkat cells with Fas ligation, and the time-course of cleavage 
of different substrates was evaluated by immunoblotting. 
Cleavage of PARP, U1-70kDa, DNA-PK~ and NuMA was 
initially observed ,~50 min after Fas ligation (Fig. 1A, Fig. 
2), and reached completion 4 h after Fas ligation (data not 
shown). The time-course of cleavage of these substrates coin- 
cided with the activation of CPP32, detected by cleavage of 
the precursor into its mature form ([18], and data not shown). 
Of note, ADP ribosylation of PARP was also readily detected 
50 min after Fas ligation, coincident with the appearance of
the proteolytic fragments (Fig. 1A) and internucleosomal 
DNA degradation (Fig. 1B). In some experiments, minimal 
PARP cleavage was also observed at 30 min. In contrast, 
the time-course of cleavage of fodrin and lamin B differed 
significantly from the substrates described above. Fodrin 
cleavage was biphasic (Fig. 2): initial cleavage began at 30 
min, generating a fragment of 150 kDa; a second phase of 
cleavage began at ,~ 50 min, producing a second fragment of 
120 kDa. This latter phase occurred co-incidently with the 
cleavage of CPP32 and its substrates (U1-70kDa, DNA- 
PKcs and PARP [16]). Cleavage of lamin B (67 kDa) was 
significantly delayed, with the 46 kDa lamin B cleavage frag- 
ment only observed 90 min after Fas ligation (Fig. 2). This is 
consistent with previous tudies which demonstrated that the 
lamin protease appears to be distinguishable from CPP32 by 
its later activation and distinct inhibition characteristics [11]. 
Thus, Fas-induced cleavage of these macromolecular protease 
substrates defines three discrete phases of proteolytic activity 
during apoptosis. The cleavage of fodrin, generating the 150 
kDa fragment, is the earliest proteolytic event occurring in 
apoptotic ells after Fas-ligation and is clearly kinetically dis- 
tinct from the cleavages catalyzed by CPP32 and similar 
homologues. This cleavage therefore provides a useful assay 
for proteolytic events that might be upstream of the activation 
of CPP32 in apoptotic ells. While the three distinct phases 
may reflect sequential activation of multiple protease activ- 
ities, they may also result from differential access of the 
same proteases to different substrates as apoptosis progresses. 
A. 
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Fig. 1. Cleavage of homeostatic proteins occurs co-incident with the 
onset of DNA fragmentation in Fas-ligated Jurkat cells. Jurkat cells 
were incubated with 200 ng/ml of anti-Fas monoclonal antibody 
CH-11 for the indicated times. At each time, the cells were har- 
vested and processed for immunoblotting (A) or for DNA gel ana- 
lysis (B) as described in the methods ection. Data shown are from 
a single xperiment, and are representative of similar data obtained 
in four other experiments. 
3.2. Inhibition characteristics of substrate cleavage in 
Fas-ligated Jurkat cells indicate the involvement of 
multiple ICE-like proteases 
To assess whether different ICE-like proteases might medi- 
ate the kinetically distinct cleavages described above, the in- 
hibition characteristics of cleavage of the different substrates 
in intact Fas-ligated cells were determined, using the peptide 
inhibitors of the ICE-like proteases, zVAD-fmk, Ac-DEVD- 
CHO and Ac-YVAD-CHO. While Ac-YVAD-CHO is a po- 
tent and specific inhibitor of ICE (Ki ICE=0.75 nM, Ki 
CPP321Mch3 =>10 gM), Ac-DEVD-CHO has a broader 
spectrum of inhibitory activity, inhibiting CPP32-1ike enzymes 
(Ki CPP32/Mch3=0.2-2 nM) only approximately 20-fold 
more potently than ICE (Ki ICE = 17 nM) [20]. The inhibition 
profile of zVAD-fmk has not yet been fully determined, 
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Fig. 2. Cleavages of structural proteins occur at different imes in Fas-ligated Jurkat cells. Jurkat cells were Fas-ligated and processed for im- 
munoblotting as described in the legend for Fig. 1. Data shown are from a single experiment, and are representative of similar data obtained 
in three other experiments. 
although it is known to inhibit ICE-like proteases [21], and to 
prevent he processing of CPP32 to its active form [22]. Thus, 
the combined profile of inhibition obtained with these re- 
agents is a useful approach with which to define the various 
ICE-like proteases active during different phases of apoptosis 
[20]. Jurkat cells were pre-incubated with the various protease 
inhibitors for 15 min, prior to activation of apoptosis by Fas- 
ligation for 90 min. Three distinct groups of cleavages could 
be defined, which correlated closely with those observed in the 
time-course studies. Firstly, the early cleavage of fodrin, 
which generated a fragment of 150 kDa, was insensitive to 
100 ~tM Ac-DEVD-CHO and 100 ~tM Ac-YVAD-CHO, but 
was entirely inhibited by 10 ~tM zVAD-fmk (Fig. 3). Sec- 
ondly, the cleavages of PARP, U1-70kDa, DNA-PKcs, 
NuMA, and the 120 kDa fragment of fodrin were inhibited 
by 100 ~tM Ac-DEVD-CHO or 10 ~tM zVAD-fmk, but only 
minimally by 100 ~tM Ac-YVAD-CHO (Fig. 3, and data not 
shown). These proteins are thus formed with identical kinetics 
after Fas ligation, and share identical inhibition characteris- 
tics, implying that similar (CPP32-1ike) activities are involved, 
directly or upstream, in all these cleavages. Lastly, cleavage of 
lamin B was abolished not only by 100 ~M Ac-DEVD-CHO 
and 10 ~tM zVAD-fmk, but was also inhibited significantly by 
100 ~tM Ac-YVAD-CHO, making it the only Ac-YVAD- 
CHO sensitive cleavage among these substrates (Fig. 3). 
3.3. A cascade of ICE-like proteases participate in apoptosis 
Several recent studies have indicated that an additional pro- 
teolytic activity is activated upstream of the CPP32-1ike pro- 
teases during Fas-induced apoptosis. For example, Dixit and 
co-workers have presented evidence that a crmA-inhibitable 
proteolytic activity is activated upstream of CPP32 in Fas- 
induced apoptosis of Jurkat cells [23]. Cohen's group has 
demonstrated in Fas-ligated Jurkat cells that zVAD-fmk but 
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Fig. 3. Inhibition of protein cleavages by ICE family inhibitors in 
Fas-ligated Jurkat cells. Jurkat cells were preincubated for 15 min 
at 37°C with 10 ktM zVAD-fmk, 100 I.tM Ac-DEVD-CHO, or 100 
ktM Ac-YVAD-CHO. Fas ligation was subsequently induced by ad- 
dition of 200 ng/ml CH-11 antibody, and further incubation at 
37°C for 90 min. The cells were harvested and processed for immu- 
noblotting as described in Section 2. Data from a single experiment 
are shown, and are representative of similar data obtained in three 
other experiments. 
not Ac-DEVD-CHO abolishes the processing of CPP32, sug- 
gesting that an additional zVAD-fmk-sensitive activity is up- 
stream of CPP32-1ike proteases in a protease cascade [22]. 
Furthermore, Enari et al. [15] have recently demonstrated 
that Fas ligation results in the early and transient activation 
of a YVAD-cleaving activity, which clearly precedes the ap- 
pearance of an DEVD-cleaving activity in W4 cells. Using 
several of the known macromolecular substrates cleaved dur- 
ing apoptosis as probes, our studies demonstrate hat the ear- 
liest cleavage vent detected to date in Fas-induced apoptosis 
is the proteolysis of fodrin which generates the 150 kDa frag- 
ment. This event is clearly distinct in terms of kinetics after 
Fas ligation, and has unique inhibition characteristics that 
separate it from all the other cleavages observed uring Fas- 
induced apoptosis of Jurkat cells. Since this fodrin cleavage is 
resistant to inhibition by Ac-DEVD-CHO, it is likely that the 
responsible protease is upstream of, and does not belong to, 
the CPP32 subfamily of proteases. The kinetic studies also 
clearly identify the cleavage of lamin B as a later proteolytic 
event, consistent with previous observations [11]. These stud- 
ies therefore provide direct evidence for an apoptotic protease 
cascade of at least three tiers following Fas ligation. Forma- 
tion of the 150 kDa fodrin fragment will provide a useful 
assay to identify and purify the upstream ICE family activity 
in the Fas-induced apoptotic pathway. It will be important to 
determine whether a similar proximal activity is activated in 
all forms of apoptotic death. 
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